Novel Drug Delivery Methods and Treatment Approaches for Retinal Diseases : Episode 1

Overview of Novel Treatments for Retinal Vascular Diseases

January 2, 2025

By Aleksandra Rachitskaya, MD
Jordan Graff, MD, FACS

Opinion

Video

A panelist discusses novel treatments for retinal vascular diseases, including faricimab, aflibercept, and port delivery system with ranibizumab.

Now Viewing

EP: 1.Overview of Novel Treatments for Retinal Vascular Diseases

EP: 2.Overview and Benefits of Port Delivery System with Ranibizumab

EP: 3.Patient Selection For Port Delivery System

EP: 4.Considerations for Surgical Implant of the Port Delivery System and Refill Process

EP: 5.Key Steps in the Surgical Implantation of the Port Delivery System

EP: 6.Patient Experiences, Key Clinical Trial Outcomes of the Port Delivery System

EP: 7.Adverse Events of the Port Delivery System and Addressing Challenges with Adoption

EP: 8.Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal Diseases

Video content above is prompted by the following:
Could you briefly provide an overview of the new treatments available for retinal vascular diseases?

Faricimab
Aflibercept 8mg
Port delivery system with ranibizumab.

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!